Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 64 (RNA5SP64) is a non-functional genomic sequence in humans that resembles the canonical 5S ribosomal RNA gene, but is classified as a pseudogene because it does not encode functional ribosomal RNA. In the human genome, many 5S rRNA pseudogenes exist as genomic relics, possibly generated by retrotransposition or duplication events. While canonical 5S rRNA is essential for ribosome structure and function, pseudogenes like RNA5SP64 are generally not transcribed or do not participate directly in translation. Some pseudogenes can be transcribed and may generate regulatory RNAs (such as siRNAs or antisense RNAs), with sporadic evidence of roles in gene expression regulation or immune responses, but there is no current evidence for such activity specifically attributed to RNA5SP64. RNA5SP64 is *not* considered a therapeutic target such as an enzyme, receptor, transporter, or channel, nor does it have known interactions with approved drugs or use as a biomarker. Key Issues: - The designation “RNA, 5S ribosomal pseudogene 64” clearly refers to a pseudogene, and therefore is **not** a functional therapeutic target. There is likely a misclassification if intended for drug targeting, assay inclusion, or pharmacological investigation—these typically focus on functional protein-coding genes or non-coding RNAs with established roles in biology or disease. - No substantial functional, pharmacological, or disease-related data are available for this specific pseudogene. Summary: **RNA5SP64** is a non-functional pseudogene corresponding to 5S ribosomal RNA and is not an established drug target, biomarker, or disease-associated gene. If structured data or therapeutic analysis is required, this object should be marked as **incorrect** (not a valid target).
None established for drugs targeting this molecule (no therapeutics known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 64 (RNA5SP64).